Etelcalcetide, an intravenous calcimimetic, was approved...
Artículos Científicos en Ingles
Artículos Científicos RSS AJKD
Racial and Ethnic Variations in Reductions in Etelcalcetide Use After Withdrawal of the Transitional Drug Add-on Payment Adjustment | Beyond Genotype: Proteomic Risk Stratification for APOL1-Mediated Kidney DiseaseThe apolipoprotein L1 (APOL1) high-risk genotypes (G1/G1... | Joint Impact of Aldosterone and Low-Density Lipoprotein Cholesterol on Cardiovascular Risk in CKDCardiovascular disease (CVD) is the leading cause of... |
Kidney Transplant Decision-Making for Candidates Over Age 75: Insights From Target Trial EmulationIn this issue of AJKD, Leeaphorn et al1 tackle a... | Weighing Ischemic Stroke and Bleeding Risks: Evaluating Discrimination and Calibration in Patients With CKD and Atrial FibrillationPatients with chronic kidney disease (CKD) and atrial... | AnnouncementThe AJKD editors are excited to continue the Editorial... |


